...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Nursing Education and Practice >Atrial fibrillation and heart failure in seven nursing homes
【24h】

Atrial fibrillation and heart failure in seven nursing homes

机译：七个疗养院的房颤和心力衰竭

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objectives:Previous research suggests that blood-thinning treatment for patients with atrial fibrillation as well as treatment for patients with heart failure is not adequate among the elderly. We tested this among long-term patients in nursing homes. Methods: Information about the patients (n = 513) was collected during the period March-April 2008. Data collection consisted of electrocardiography, particulars of any stroke suffered and copying medication records. A standardized set of blood samples was analyzed. Results: Of the 91 atrial fibrillation patients, 14.3% were anticoagulated with warfarin. 42.0% of the patients with atrial fibrillation had no form of antithrombotic treatment. Prevalence of atrial fibrillation was 18.8% and high B-type natriuretic peptide (ProBNP 225 pmol/L) 13.2%. Of the patients with both stroke and atrial fibrillation, 24.3% were given warfarin. Of the 59 patients with ProBNP 225 pmol/L and adequate renal function (eGFR 50 ml/min), 22.0% were given ACE/A2B. Conclusions: The warfarin treatment rate was lower than recommended for patients with atrial fibrillation in nursing homes, as was probably the use of ACE-inhibitors to heart -failure patients. We found significant differences between the nursing homes with regard to treatment rate. Atrial fibrillation and heart failure case finding and monitoring in nursing homes needs to be improved and simple tools like recording and reporting irregular pulse by doctors and nurses and measure ProBNP on a regular basis may improve this.
机译：目的：先前的研究表明，对于房颤患者的血液稀释治疗以及对心力衰竭患者的治疗不足。我们在疗养院的长期患者中对此进行了测试。方法：在2008年3月至4月期间收集了有关患者的信息（n = 513）。数据收集包括心电图，任何中风的详细资料和复制用药记录。分析了一套标准化的血液样本。结果：91例房颤患者中，华法林抗凝治疗率为14.3％。房颤患者中有42.0％的患者未进行任何形式的抗栓治疗。心房颤动的患病率为18.8％，高B型钠尿肽（ProBNP> 225 pmol / L）的患病率为13.2％。在中风和房颤患者中，有24.3％给予华法林治疗。在ProBNP> 225 pmol / L且肾功能适当（eGFR> 50 ml / min）的59例患者中，有22.0％的患者接受了ACE / A2B。结论：疗养院中房颤患者的华法林治疗率低于推荐水平，心力衰竭患者可能使用ACE抑制剂。我们发现疗养院之间在治疗率方面存在显着差异。需要改善疗养院中的心房颤动和心力衰竭病例的发现和监视，而简单的工具（例如由医生和护士记录和报告不规则脉搏并定期测量ProBNP）可能会改善这一情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号